Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease

Published:2018-12-01 Issue:suppl_1 Volume:11 Page:i27-i38
ISSN:2048-8505
Container-title:Clinical Kidney Journal
language:en
Short-container-title:

Author:

Weimbs Thomas¹^ORCID,Shillingford Jonathan M²,Torres Jacob¹,Kruger Samantha L¹,Bourgeois Bryan C¹

Affiliation:

1. Department of Molecular, Cellular, and Developmental Biology; and Neuroscience Research Institute, University of California, Santa Barbara, CA, USA

2. Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI, USA

Funder

National Institutes of Health

Lillian Goldman Charitable Trust

Amy P. Goldman Foundation to University of California Santa Barbara

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ckj/article-pdf/11/suppl_1/i27/27040069/sfy089.pdf

Reference143 articles.

1. mTOR ignaling in growth, metabolism, and disease;Saxton;Cell,2017

2. Mammalian target of rapamycin inhibition in polycystic kidney disease: from bench to bedside;Kim;Kidney Res Clin Pract,2012

3. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease;Shillingford;Proc Natl Acad Sci USA,2006

4. Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1;Shillingford;J Am Soc Nephrol,2010

5. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease;Zafar;Kidney Int,2010

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence;Nutrients;2024-08-13

2. Activation of farnesoid X receptor retards expansion of renal collecting duct cell-derived cysts via inhibition of CFTR-mediated Cl^– secretion;American Journal of Physiology-Renal Physiology;2024-04-01

3. Zystische Nierenerkrankungen im Kindesalter;Therapie der Krankheiten im Kindes- und Jugendalter;2024

4. Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers;Frontiers in Pediatrics;2023-11-10

5. Development and Validation of a Nomogram for Renal Survival Prediction in Patients with Autosomal Dominant Polycystic Kidney Disease;Kidney Diseases;2023-06-06